A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Public ClinicalTrials.gov record NCT07282613. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. Once Weekly Versus Placebo in Children and Adolescents With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical study is to look into how well a study medicine called CagriSema helps children and adolescents living with diabetes lower their blood sugar and body weight. The study has 2 parts: in the first part participant will get either CagriSema or placebo, and in the second part participant will get CagriSema. In the first part, which treatment participant gets is decided by chance and second part is open label and all participants will get CagriSema during this part. The study will last for about 1 year and 3 months.
Study identification
- NCT ID
- NCT07282613
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- CagriSema (Cagrilintide B and Semaglutide I) Drug
- Placebo matched to CagriSema (Cagrilintide B and Semaglutide I) Drug
Drug
Eligibility (public fields only)
- Age range
- 10 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 3, 2026
- Primary completion
- Sep 6, 2029
- Completion
- Mar 29, 2030
- Last update posted
- Sep 8, 2026
2026 – 2030
United States locations
- U.S. sites
- 21
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yale School of Medicine | New Haven | Connecticut | 06511 | Not yet recruiting |
| Encore Medical Research Boynton Beach | Boynton Beach | Florida | 33436 | Recruiting |
| Nemours Chld Clnc Jacksonville | Jacksonville | Florida | 32207 | Recruiting |
| Innovus Clinical | Kissimmee | Florida | 34741 | Recruiting |
| D&H National Research Centers | Tamarac | Florida | 33321 | Recruiting |
| Clinical Research Trials of Florida | Tampa | Florida | 33607 | Recruiting |
| Columbus Research Foundation | Columbus | Georgia | 31904 | Recruiting |
| Eastside Bariatric and Gen Surg | Snellville | Georgia | 30078 | Recruiting |
| SIU Medicine | Springfield | Illinois | 62702 | Not yet recruiting |
| Riley Hospital For Children | Indianapolis | Indiana | 46202 | Not yet recruiting |
| University of Iowa | Iowa City | Iowa | 52242 | Recruiting |
| Great Lakes Research Inst. | Southfield | Michigan | 48075 | Recruiting |
| UBMD Pediatrics | Buffalo | New York | 14203 | Not yet recruiting |
| NYU Langone Orthopedic Center | New York | New York | 10016 | Not yet recruiting |
| Children's Hosptl Philadelphia | Philadelphia | Pennsylvania | 19104 | Not yet recruiting |
| Monument Health Clinical Rsrch | Rapid City | South Dakota | 57701 | Not yet recruiting |
| LifeDoc Health | Memphis | Tennessee | 38115 | Recruiting |
| Amir Ali Hassan, MD, PA | Houston | Texas | 77089 | Recruiting |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | Recruiting |
| UVA Health Systems | Charlottesville | Virginia | 22903 | Recruiting |
| Seattle Children's Research Institute | Seattle | Washington | 98105 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07282613, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 8, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07282613 live on ClinicalTrials.gov.